Correlation Between Pieris Pharmaceuticals and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and PDS Biotechnology Corp, you can compare the effects of market volatilities on Pieris Pharmaceuticals and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and PDS Biotechnology.
Diversification Opportunities for Pieris Pharmaceuticals and PDS Biotechnology
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pieris and PDS is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and PDS Biotechnology
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to generate 1.43 times more return on investment than PDS Biotechnology. However, Pieris Pharmaceuticals is 1.43 times more volatile than PDS Biotechnology Corp. It trades about 0.02 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.05 per unit of risk. If you would invest 1,631 in Pieris Pharmaceuticals on August 24, 2024 and sell it today you would lose (38.00) from holding Pieris Pharmaceuticals or give up 2.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pieris Pharmaceuticals vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Pieris Pharmaceuticals |
| PDS Biotechnology Corp |
Pieris Pharmaceuticals and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pieris Pharmaceuticals and PDS Biotechnology
The main advantage of trading using opposite Pieris Pharmaceuticals and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Pieris Pharmaceuticals vs. CytomX Therapeutics | Pieris Pharmaceuticals vs. Instil Bio | Pieris Pharmaceuticals vs. Spero Therapeutics | Pieris Pharmaceuticals vs. Assembly Biosciences |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |